<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Sphingomyelin distinguishes treatment futility vs. response in metastatic colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Sphingomyelin</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>treatment futility vs. response in metastatic colorectal cancer</strong>
</div>
<div class="entity-id">HMDB:HMDB0000252 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:0%;--color:#d62728"></div>
<div class="stat-row">
  <span>Class: AI Generated (0.01)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 0.09<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#d62728" title="AI Generated"></span><span>AI Generated</span><a href="https://doi.org/10.18632/oncotarget.28165">10.18632/oncotarget.28165</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 9 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>4</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Brivanib — causes → Hypertension</span><a href="../claim/6a7fae877f755fc9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Phosphatidylcholine — distinguishes → Brivanib-induced hypertension</span><a href="../claim/5055fcae71924d56.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LPC) — is_biomarker_for → Brivanib-induced hypertension</span><a href="../claim/9bb697aef1f62008.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Brivanib — inhibits → FGFR</span><a href="../claim/89abfcc587d15524.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>4</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Brivanib-induced hypertension — predicts → Overall survival in metastatic colorectal cancer</span><a href="../claim/b1712dd89d9a1101.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LPC) — distinguishes → Brivanib-induced hypertension</span><a href="../claim/82a3bed01a275c34.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Sphingomyelin — distinguishes → Brivanib-induced hypertension</span><a href="../claim/af14263ea5d6b85e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Brivanib — treats → Metastatic colorectal cancer</span><a href="../claim/2a19e047075cea7a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:25px"></span><span>1</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Brivanib — inhibits → VEGFR</span><a href="../claim/b1f45dd778144156.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>985054e11c4d34ac</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000252">HMDB:HMDB0000252</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
